223 related articles for article (PubMed ID: 8033102)
1. Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer.
Macoska JA; Trybus TM; Sakr WA; Wolf MC; Benson PD; Powell IJ; Pontes JE
Cancer Res; 1994 Jul; 54(14):3824-30. PubMed ID: 8033102
[TBL] [Abstract][Full Text] [Related]
2. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.
Bova GS; Carter BS; Bussemakers MJ; Emi M; Fujiwara Y; Kyprianou N; Jacobs SC; Robinson JC; Epstein JI; Walsh PC
Cancer Res; 1993 Sep; 53(17):3869-73. PubMed ID: 7689419
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer.
Tsuchiya N; Slezak JM; Lieber MM; Bergstralh EJ; Jenkins RB
Genes Chromosomes Cancer; 2002 Aug; 34(4):363-71. PubMed ID: 12112525
[TBL] [Abstract][Full Text] [Related]
4. Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization.
Matsuyama H; Pan Y; Skoog L; Tribukait B; Naito K; Ekman P; Lichter P; Bergerheim US
Oncogene; 1994 Oct; 9(10):3071-6. PubMed ID: 8084616
[TBL] [Abstract][Full Text] [Related]
5. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
[TBL] [Abstract][Full Text] [Related]
6. Homozygous and frequent deletion of proximal 8p sequences in human prostate cancers: identification of a potential tumor suppressor gene site.
Prasad MA; Trybus TM; Wojno KJ; Macoska JA
Genes Chromosomes Cancer; 1998 Nov; 23(3):255-62. PubMed ID: 9790507
[TBL] [Abstract][Full Text] [Related]
7. A molecular cytogenetic analysis of 7q31 in prostate cancer.
Jenkins RB; Qian J; Lee HK; Huang H; Hirasawa K; Bostwick DG; Proffitt J; Wilber K; Lieber MM; Liu W; Smith DI
Cancer Res; 1998 Feb; 58(4):759-66. PubMed ID: 9485032
[TBL] [Abstract][Full Text] [Related]
8. Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer.
Macoska JA; Trybus TM; Benson PD; Sakr WA; Grignon DJ; Wojno KD; Pietruk T; Powell IJ
Cancer Res; 1995 Nov; 55(22):5390-5. PubMed ID: 7585607
[TBL] [Abstract][Full Text] [Related]
9. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM
Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer.
Huang SF; Xiao S; Renshaw AA; Loughlin KR; Hudson TJ; Fletcher JA
Am J Pathol; 1996 Nov; 149(5):1565-73. PubMed ID: 8909246
[TBL] [Abstract][Full Text] [Related]
11. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21.
Vocke CD; Pozzatti RO; Bostwick DG; Florence CD; Jennings SB; Strup SE; Duray PH; Liotta LA; Emmert-Buck MR; Linehan WM
Cancer Res; 1996 May; 56(10):2411-6. PubMed ID: 8625320
[TBL] [Abstract][Full Text] [Related]
12. Allelotyping analysis at chromosome arm 8p of high-grade prostatic intraepithelial neoplasia and incidental, latent, and clinical prostate cancers.
Lu W; Takahashi H; Furusato B; Maekawa S; Ikegami M; Sudo A; Egawa S; Hano H
Genes Chromosomes Cancer; 2006 May; 45(5):509-15. PubMed ID: 16470536
[TBL] [Abstract][Full Text] [Related]
13. Haploinsufficiency of 8p22 may influence cancer-specific survival in prostate cancer.
Matsuyama H; Oba K; Matsuda K; Yoshihiro S; Tsukamoto M; Kinjo M; Sagiyama K; Takei M; Yamaguchi A; Sasaki K; Naito K
Cancer Genet Cytogenet; 2007 Apr; 174(1):24-34. PubMed ID: 17350463
[TBL] [Abstract][Full Text] [Related]
14. Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer.
El Gammal AT; Brüchmann M; Zustin J; Isbarn H; Hellwinkel OJ; Köllermann J; Sauter G; Simon R; Wilczak W; Schwarz J; Bokemeyer C; Brümmendorf TH; Izbicki JR; Yekebas E; Fisch M; Huland H; Graefen M; Schlomm T
Clin Cancer Res; 2010 Jan; 16(1):56-64. PubMed ID: 20028754
[TBL] [Abstract][Full Text] [Related]
15. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
[TBL] [Abstract][Full Text] [Related]
16. Allelic loss in locally metastatic, multisampled prostate cancer.
Sakr WA; Macoska JA; Benson P; Grignon DJ; Wolman SR; Pontes JE; Crissman JD
Cancer Res; 1994 Jun; 54(12):3273-7. PubMed ID: 7515768
[TBL] [Abstract][Full Text] [Related]
17. Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer.
Trybus TM; Burgess AC; Wojno KJ; Glover TW; Macoska JA
Cancer Res; 1996 May; 56(10):2263-7. PubMed ID: 8625295
[TBL] [Abstract][Full Text] [Related]
18. Deletions on chromosome 8p22 may predict disease progression as well as pathological staging in prostate cancer.
Matsuyama H; Pan Y; Oba K; Yoshihiro S; Matsuda K; Hägarth L; Kudren D; Naito K; Bergerheim US; Ekman P
Clin Cancer Res; 2001 Oct; 7(10):3139-43. PubMed ID: 11595707
[TBL] [Abstract][Full Text] [Related]
19. Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization.
Visakorpi T; Hyytinen E; Kallioniemi A; Isola J; Kallioniemi OP
Am J Pathol; 1994 Sep; 145(3):624-30. PubMed ID: 8080044
[TBL] [Abstract][Full Text] [Related]
20. The role of chromosome 8p22 deletion for predicting disease progression and pathological staging in prostate cancer.
Matsuyama H; Pan Y; Oba K; Yoshihiro S; Matsuda K; Hägarth L; Kudren D; Naito K; Bergerheim US; Ekman P
Aktuelle Urol; 2003 Jul; 34(4):247-9. PubMed ID: 14566675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
